
PureTech Secures Orphan Drug Designations in U.S. and EU for Deupirfenidone (LYT-100) in IPF
PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis PureTech Health plc a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value,…












